Trials / Completed
CompletedNCT02055742
Detection of Chlamydia (CT) and Gonorrhea (NG)
Clinical Study Protocol for the Illumigene® Chlamydia and Illumigene® Gonorrhea DNA Amplification Assays
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- Meridian Bioscience, Inc. · Industry
- Sex
- All
- Age
- 14 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the illumipro-10, with male urine, female urine, physician-collected (medical professional) endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic patient populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | illumigene CT and NG assays, illumipro-10 |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-09-09
- Completion
- 2014-09-09
- First posted
- 2014-02-05
- Last updated
- 2017-12-07
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02055742. Inclusion in this directory is not an endorsement.